At the end of the latest market close, VBI Vaccines Inc. (VBIV) was valued at $0.60. In that particular session, Stock kicked-off at the price of $0.5918 while reaching the peak value of $0.6199 and lowest value recorded on the day was $0.5331. The stock current value is $0.55.Recently in News on December 8, 2022, VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults. VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Health Canada has approved PreHevbrio™ [3-antigen Hepatitis B Vaccine (Recombinant)] for active immunization against infection caused by all known subtypes of hepatitis B (HBV) virus in adults 18 years of age and older. It can be expected that hepatitis D will also be prevented by immunization with PreHevbrio as hepatitis D (caused by the delta agent) does not occur in the absence of hepatitis B infection. You can read further details here
VBI Vaccines Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.7000 on 01/18/23, with the lowest value was $0.4000 for the same time period, recorded on 01/03/23.
VBI Vaccines Inc. (VBIV) full year performance was -69.89%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, VBI Vaccines Inc. shares are logging -70.53% during the 52-week period from high price, and 53.06% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.36 and $1.87.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 989318 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the VBI Vaccines Inc. (VBIV) recorded performance in the market was 40.88%, having the revenues showcasing -12.89% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 142.33M, as it employees total of 149 workers.
Specialists analysis on VBI Vaccines Inc. (VBIV)
During the last month, 0 analysts gave the VBI Vaccines Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.6279, with a change in the price was noted -0.35. In a similar fashion, VBI Vaccines Inc. posted a movement of -39.06% for the period of last 100 days, recording 949,716 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for VBIV is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.58.
Trends and Technical analysis: VBI Vaccines Inc. (VBIV)
Raw Stochastic average of VBI Vaccines Inc. in the period of last 50 days is set at 56.18%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 56.18%. In the last 20 days, the company’s Stochastic %K was 66.22% and its Stochastic %D was recorded 74.26%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 40.88%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -38.78%, alongside a downfall of -69.89% for the period of the last 12 months. The shares increased approximately by -0.74% in the 7-day charts and went down by 25.46% in the period of the last 30 days. Common stock shares were lifted by -12.89% during last recorded quarter.